Back to top
more

Medtronic (MDT)

(Delayed Data from NYSE)

$89.67 USD

89.67
5,001,632

+0.03 (0.03%)

Updated Aug 5, 2025 04:00 PM ET

After-Market: $89.66 -0.01 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 37% (155 out of 246)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Medtronic (MDT) Laps the Stock Market: Here's Why

by Zacks Equity Research

In the closing of the recent trading day, Medtronic (MDT) stood at $91.69, denoting a +0.79% change from the preceding trading day.

Urmimala Biswas headshot

Trump Tariffs Threaten MedTech: 3 Stocks to Mitigate Risks

by Urmimala Biswas

Three companies that are better positioned to withstand Trump's tariff challenges are ResMed, Hims & Hers Health and Medtronic.

Zacks Equity Research

Medtronic (MDT) Outperforms Broader Market: What You Need to Know

by Zacks Equity Research

In the most recent trading session, Medtronic (MDT) closed at $91.99, indicating a +0.63% shift from the previous trading day.

Zacks Equity Research

ResMed (RMD) Tops Q2 Earnings and Revenue Estimates

by Zacks Equity Research

ResMed (RMD) delivered earnings and revenue surprises of 5.65% and 1.57%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Urmimala Biswas headshot

BSX Pre-Q4 Earnings: To Buy or Not to Buy Boston Scientific Stock Now?

by Urmimala Biswas

Boston Scientific is expected to have registered strong growth in the Asia Pacific in the fourth quarter, led by strength in China and Japan.

Indrajit Bandyopadhyay headshot

Is ISRG a Buy After Logging Robust System Placements in Q4?

by Indrajit Bandyopadhyay

Intuitive Surgical has maintained an uptrend so far this year on the back of robust da Vinci portfolio performance. The stock has also gained during the past month. Let's see if the trend might change.

Zacks Equity Research

Medtronic (MDT) Increases Despite Market Slip: Here's What You Need to Know

by Zacks Equity Research

Medtronic (MDT) closed at $90.19 in the latest trading session, marking a +1.05% move from the prior day.

Debanjana Dey headshot

TMDX Stock Plunges 49.2% in Three Months: What's Behind the Downfall?

by Debanjana Dey

TransMedics is navigating macroeconomic challenges amid its focus on meaningful progress across each of its growth initiatives.

Indrajit Bandyopadhyay headshot

ISRG Likely to Beat Q4 Expectations: How to Play the Stock?

by Indrajit Bandyopadhyay

Intuitive Surgical's fourth-quarter results are likely to reflect solid performance in the company's Instruments & Accessories segment. Improving margins buoy optimism.

Urmimala Biswas headshot

Abbott Stock Ahead of Q4 Earnings Results: Smart Buy or Risky Move?

by Urmimala Biswas

Abbott's Diagnostics arm is expected to have been driven by the widespread adoption of its top-tier systems and high testing demand in the fourth quarter.

Urmimala Biswas headshot

BLS Data Shows Slowdown in Core CPI: Time to Buy MDT Stock Now?

by Urmimala Biswas

Medtronic's strong liquidity position should allow it to meet its near-term debt obligations.

Zacks Equity Research

Here's Why Medtronic (MDT) Gained But Lagged the Market Today

by Zacks Equity Research

Medtronic (MDT) concluded the recent trading session at $85.40, signifying a +0.18% move from its prior day's close.

Urmimala Biswas headshot

M&A Synergies Drive BSX: Is it Worth Buying the Stock Now?

by Urmimala Biswas

Boston Scientific's recent acquisitions have added numerous products with immense potential.

Zacks Equity Research

J&J Pauses Sales of Atrial Fibrillation Device, Stock Down

by Zacks Equity Research

J&J's MedTech unit pauses all cases of the Varipulse PFA system as part of an external evaluation. Stock dips.

Zacks Equity Research

Here's Why Medtronic (MDT) Gained But Lagged the Market Today

by Zacks Equity Research

Medtronic (MDT) closed at $80.95 in the latest trading session, marking a +0.91% move from the prior day.

Zacks Equity Research

Reasons to Retain Medtronic Stock in Your Portfolio Now

by Zacks Equity Research

Investors continue to be optimistic about MDT due to its impressive Neuroscience portfolio. Yet, the dull macroeconomic scenario poses a concern to the company's margins.

Indrajit Bandyopadhyay headshot

5 Top AI-in-MedTech Stocks for Big Gains in 2025: MDT, BSX & More

by Indrajit Bandyopadhyay

Here we discuss five medical stocks - MDT, BSX, BDX, GEHC and TEM - incorporating AI in their workflows. These are likely to gain in 2025 as AI helps cut costs and improve patient care.

Zacks Equity Research

Medtronic (MDT) Stock Moves -1.05%: What You Should Know

by Zacks Equity Research

Medtronic (MDT) closed the most recent trading day at $80.74, moving -1.05% from the previous trading session.

Urmimala Biswas headshot

Is Abbott Stock Worth Buying at a Discounted P/S Valuation?

by Urmimala Biswas

Abbott's strong market position, promising growth prospects and consistent share gains make it a compelling pick for investors.

Urmimala Biswas headshot

Medtronic Stock Declines 5.6% in a Month: Time to Buy the Dip?

by Urmimala Biswas

MDT stock suffers as a result of geopolitical complications and supply issues despite an expanding portfolio and strong strategic executions.

Urmimala Biswas headshot

BSX Trades Near 52-Week High: Does the Stock Hold More Potential?

by Urmimala Biswas

We believe Boston Scientific is one of those MedTech manufacturers that can be considered as the biggest gainers from the Fed's two successive interest rate cuts in 2024.

Debanjana Dey headshot

TransMedics Stock Plunges 57.5% in Three Months: What's Next?

by Debanjana Dey

TMDX is enhancing its current focus on making meaningful progress across each of its growth initiatives. However, macro challenges are likely to hurt its performance.

Indrajit Bandyopadhyay headshot

ISRG Stock Reaches All-Time High: Strength in Uptrend to Continue?

by Indrajit Bandyopadhyay

Intuitive Surgical has maintained an uptrend so far this year on the back of robust da Vinci portfolio performance. The has stock also gained during the past month. Let's see if the trend might change.

Zacks Equity Research

Reasons to Retain Medtronic Stock in Your Portfolio Now

by Zacks Equity Research

Investors continue to be optimistic about MDT due to its impressive international expansion. Yet, the dull macroeconomic scenario poses a concern to the company's margins.

Zacks Equity Research

MDT Stock May Gain Following the Positive Data From Optimize PRO Study

by Zacks Equity Research

Medtronic announces new positive data for its Evolut TAVR from the Optimize PRO clinical research.